Decoy Therapeutics Inc (DCOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,010 | -4,269 | -2,282 | N/A | N/A |
| Depreciation Amortization | 10 | 6 | 2 | N/A | N/A |
| Accounts payable and accrued liabilities | 254 | 279 | 400 | N/A | N/A |
| Other Working Capital | 1 | 368 | 642 | N/A | N/A |
| Other Operating Activity | 1,265 | 449 | -24 | 0 | 0 |
| Operating Cash Flow | $-6,480 | $-3,166 | $-1,263 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -70 | -59 | -34 | N/A | N/A |
| Investing Cash Flow | $-70 | $-59 | $-34 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11 | 9 | 2 | N/A | N/A |
| Other Financing Activity | 40,400 | 39,508 | 15,582 | 0 | 0 |
| Financing Cash Flow | $40,410 | $39,517 | $15,584 | $N/A | $N/A |
| End Cash Position | 33,850 | 36,292 | 14,287 | N/A | N/A |
| Net Cash Flow | $33,850 | $36,292 | $14,287 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,480 | -3,166 | -1,263 | N/A | N/A |
| Capital Expenditure | -76 | -59 | -34 | N/A | N/A |
| Free Cash Flow | -6,556 | -3,225 | -1,297 | 0 | 0 |